Atlas Trials

Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma

Clinical trial NCT01736878 · WITHDRAWN

Trial details

NCT number
NCT01736878
Sponsor
Eanm Research Ltd
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Medullary Thyroid Carcinoma
Start date
2012-10-01
Primary completion
2013-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.